Skip to main content
. Author manuscript; available in PMC: 2020 Jun 8.
Published in final edited form as: Methods Mol Biol. 2019;2001:41–59. doi: 10.1007/978-1-4939-9504-2_3

Figure 4.

Figure 4.

Structures of reversibly cyclized cell-permeable peptidyl inhibitors. (a) A monocyclic peptidyl inhibitor against the CFTR-CAL interaction, and b) a bicyclic peptidyl inhibitor against the NEMO-IKK interaction.